Articles tagged with 'Export-LatestNews' | Bayer

Newsroom Bayer (Export-LatestNews)

2023
March
24,
2023
| 14:59 PM Europe/Amsterdam
Late-stage development programs with significant potential to drive long-term growth / New R&D strategy and operating model sharpening innovation focus and strengthening early development pipeline in oncology, cardiovascular, neurology & rare disease...
Read more
March
23,
2023
| 13:59 PM Europe/Amsterdam
Phase III study ARASTEP initiated in hormone-sensitive prostate cancer, in patients with high-risk biochemical recurrence (BCR) who have no evidence of metastatic disease by conventional imaging and a positive PSMA PET/CT at baseline / Fifth major cl...
Read more
March
21,
2023
| 10:59 AM Europe/Amsterdam
Holistic approach to improve water use and quality across the entire value chain and contribute to an impactful change / Integration of water stewardship in business and investment decisions / Shaping a water-resilient agriculture system with key con...
Read more
March
20,
2023
| 07:59 AM Europe/Amsterdam
Nubeqa™ now approved for metastatic hormone-sensitive prostate cancer as well as non-metastatic castration-resistant prostate cancer / Additional indication based on data from the pivotal Phase III ARASENS trial ...
Read more
March
14,
2023
| 12:59 PM Europe/Amsterdam
Ready-to-use AgPowered Services from Bayer running on the new Microsoft Azure Data Manager for Agriculture / Readymade capabilities and robust digital infrastructure allow innovators to focus on differentiated value / Companies, farmers and consumers...
Read more
March
14,
2023
| 12:45 PM Europe/Amsterdam
Rune Labs’ StriveStudy platform and Emerald Innovations’ Emerald wireless monitoring sensor will passively capture data on Parkinson’s disease impact on function of fifty study participants in BlueRock’s global non-interventional clinical study.  / C...
Read more
March
09,
2023
| 16:14 PM Europe/Amsterdam
Research Triangle Park, N.C.– March 9, 2023 – Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, today announced that Gustavo Pesquin will become the company’s next Chief Executive Officer (C...
Read more
March
07,
2023
| 08:59 AM Europe/Amsterdam
Basel, Switzerland, March 7, 2023 — A first-of-its-kind collaboration in the consumer health industry is developing a platform aimed at reducing or replacing animal testing using “organ-on-chip” (OoC) technology and interactive computational software...
Read more
March
06,
2023
| 09:59 AM Europe/Amsterdam
In the prospective observational XARENO study, after a two year follow up period, Xarelto was associated with a reduced risk of adverse kidney outcomes and all-cause mortality in patients with non-valvular atrial fibrillation (NVAF) and advanced chro...
Read more
March
01,
2023
| 11:59 AM Europe/Amsterdam
European Commission granted approval of Nubeqa™ (darolutamide) for the treatment of patients with metastatic hormone-sensitive prostate cancer (mHSPC) / Approval is based on Phase III ARASENS trial data...
Read more
March
01,
2023
| 07:59 AM Europe/Amsterdam
Submission to the Ministry of Health, Labor, and Welfare (MHLW) in Japan for aflibercept 8 mg in neovascular (wet) age-related macular degeneration (nAMD) and diabetic macular edema (DME) is based on positive results of phase III clinical trials, PUL...
Read more
February
28,
2023
| 07:30 AM Europe/Amsterdam
Group sales increase 8.7 percent (Fx & portfolio adj.) to 50.739 billion euros / EBITDA before special items rises 20.9 percent to 13.513 billion euros, largely driven by exceptionally strong performance at Crop Science / Pharmaceuticals increases sa...
Read more
February
27,
2023
| 09:59 AM Europe/Amsterdam
Agnes Binagwaho, Dante Pesce and Jeffrey Ubben appointed to independent Sustainability Council / New personnel enhance the council’s subject matter expertise in key focus areas such as access to medicine, human rights and sustainable finance / Brauli...
Read more
February
27,
2023
| 07:59 AM Europe/Amsterdam
Darolutamide approved for metastatic prostate cancer as well as non-metastatic castration-resistant prostate cancer / New approval based on data from the pivotal Phase III ARASENS trial 
Read more
February
23,
2023
| 08:29 AM Europe/Amsterdam
The Nutrient Gap Initiative, aiming to improve access to essential nutrients for 50 million people by 2030, expands its scope to include both supplementation and food
Read more
February
22,
2023
| 08:29 AM Europe/Amsterdam
Featured presentations include development compound gadoquatrane, a novel contrast agent for MRI / Further research explores potential of AI and digital advances in medical imaging 
Read more
February
16,
2023
| 19:59 PM Europe/Amsterdam
New subgroup analysis from Phase III ARASENS trial shows that darolutamide plus androgen deprivation therapy (ADT) in combination with docetaxel increased overall survival (OS) and improved key clinically relevant endpoints in patients with various t...
Read more
February
13,
2023
| 08:29 AM Europe/Amsterdam
Closing follows announcement of acquisition on January 18, 2023 / Acquisition bolsters Bayer’s position in digital medical imaging / Blackford will utilize Bayer’s well established “arm’s length” operating model to preserve the company’s entrepreneur...
Read more
February
10,
2023
| 09:59 AM Europe/Amsterdam
European Commission granted approval for a label update to extend the indication of Kerendia™ to early stages of chronic kidney disease (CKD) associated with type 2 diabetes (T2D) and to include findings from the Phase III FIGARO-DKD cardiovascular (...
Read more
February
08,
2023
| 17:14 PM Europe/Amsterdam
Leverkusen, February 8, 2023 – The Supervisory Board of Bayer AG has appointed Bill Anderson to become CEO of Bayer, effective June 1, 2023. He will join Bayer as a member of the Board of Management on April 1, 2023. Bill Anderson was elected unanimo...
Read more
February
08,
2023
| 09:59 AM Europe/Amsterdam
Bayer provides 1 million euros for immediate aid to Türkiye via the disaster relief organizations Red Crescent and Ahbap as well as 200.000 euros to Syria via the German Red Cross / A global employee donation campaign for both Türkiye and Syria will ...
Read more
February
08,
2023
| 08:59 AM Europe/Amsterdam
Partnering with players along the food value chain is key to tackle challenges of food security and climate change / Bayer makes substantial progress in accelerating development of biologicals through collaborations with Ginkgo Bioworks, Kimitec and ...
Read more
February
06,
2023
| 10:59 AM Europe/Amsterdam
Filing for aflibercept 8 mg in neovascular (wet) age-related macular degeneration (nAMD) and diabetic macular edema (DME) is based on positive results of clinical trials, PULSAR and PHOTON / In both trials, aflibercept 8 mg demonstrated unprecedented...
Read more
February
02,
2023
| 08:59 AM Europe/Amsterdam
Both companies enter into a global strategic partnership for Biologicals discovery and commercialization, that includes crop protection and biostimulant products based on molecules derived from natural sources / Kimitec becomes a new strategic partne...
Read more
January
31,
2023
| 14:58 PM Europe/Amsterdam
The Professor at the Institute of Organic Chemistry at the University of Münster receives the award in recognition of his groundbreaking work / Professor Antje Boetius, Director of the Alfred Wegener Institute (AWI) in Bremerhaven, is presented with ...
Read more
January
31,
2023
| 08:59 AM Europe/Amsterdam
Biological pheromones present a non-toxic, innovative opportunity for biological crop protection while safeguarding biodiversity and beneficial pollinators / M2i’s patented bio-sourced micro-encapsulation technology means long-lasting pheromone contr...
Read more
January
27,
2023
| 12:59 PM Europe/Amsterdam
CHMP recommendation is based on Phase III data, which demonstrated that darolutamide plus androgen deprivation therapy (ADT) in combination with docetaxel significantly reduced the risk of death by 32.5% compared to ADT with docetaxel alone, with sim...
Read more
January
24,
2023
| 13:59 PM Europe/Amsterdam
Jeffrey Hatfield becomes Chairman of the Board of Directors at Vividion Therapeutics
Read more
January
23,
2023
| 08:29 AM Europe/Amsterdam
Ultravist™-300, -370 receives green light for indication extension for use in contrast-enhanced mammography (CEM) in a European Workshare Procedure  / CEM is emerging modality combining digital mammography with the administration of a contrast agent ...
Read more